In 2026, the application of AI in the medical field is entering a comprehensive outbreak period. From intelligent imaging diagnosis to AI assisted drug development, deep learning technology is reshaping every aspect of modern medicine.
In terms of medical imaging diagnosis, AI systems based on Convolutional Neural Networks (CNN) have achieved higher accuracy in lesion recognition in X-ray, CT, and MRI images than experienced radiologists. Taking pulmonary nodule detection as an example, the latest generation AI model achieved a detection rate of 98.7% in low-dose CT screening, with a false positive rate reduced to 0.3 per case, greatly improving the diagnostic efficiency of early lung cancer.
AI drug development is another exciting frontier. The traditional drug discovery process takes an average of 10-15 years and costs over 1 billion US dollars. And AI can shorten the discovery cycle of lead compounds to several months through molecular simulation, virtual screening, and generative chemistry. At the beginning of 2026, Insilico Medicine's AI discovery drug has entered phase II clinical trials, marking the transition of AI drug development from concept validation to clinical implementation.
In the field of genomics, AI models can identify pathogenic mutation sites from massive gene sequences, assisting in accurate diagnosis of rare diseases. The AI system developed by Deep Genomics can analyze complete exome data within minutes and provide diagnostic recommendations for clinical doctors.
AI is also changing surgical methods. After being equipped with AI assisted modules, the Da Vinci surgical system can analyze the surgical field of view in real time, predict intraoperative risks, and provide decision support to the chief surgeon. At the end of 2025, the US FDA approved the first fully autonomous AI ophthalmic surgical system specifically designed for preoperative planning of cataracts.
China has also shown impressive performance in the field of AI healthcare. Tencent Miying, Baidu Lingyi Zhitan and other platforms have been launched in hundreds of hospitals across the country, covering AI assisted diagnosis of lung cancer, esophageal cancer, diabetes retinopathy and other diseases. The "Blue Book on the Development of AI Healthcare in China" released in March 2026 shows that AI assisted diagnosis has covered 60% of the top three hospitals in the country.
Looking ahead to the future, multimodal AI models will integrate multiple sources of data such as images, genomes, and electronic medical records to achieve truly personalized healthcare. From diagnosis to treatment to prognosis management, AI is cutting into every corner of the medical system with precision like a surgical knife. 【 Reference source 】 Comprehensive compilation of industry information released publicly. <｜end▁of▁thinking｜> Now let me select categories and publish via dispatchEvent.
<｜｜DSML｜｜tool_calls>
<｜｜DSML｜｜invoke name="browser_console">
<｜｜DSML｜｜parameter name="expression" string="true"> Technology, Information forEach(function(cat) { var _b = [...document.querySelectorAll('button')].find(b => b.textContent.trim() === cat); if(_b) _b.dispatchEvent(new MouseEvent('click', {bubbles:true, cancelable:true})); });